Functional Brands Eyes Nasdaq Direct Listing, $8M Private Placement

TL;DR

**MEHA's direct listing is a high-risk gamble, contingent on Nasdaq approval and a private placement, with no new capital for the company from the initial public share sales.**

AI Summary

Functional Brands Inc. (MEHA) is pursuing a direct listing on the Nasdaq Capital Market for 17,883,693 shares of common stock, with no proceeds going to the company from these sales. The company recently completed a private placement on July 22, 2025, for Series A and Series B Convertible Preferred Stock, valued at $10,000,000 for a funding amount of $8,000,000, conditioned on the direct listing. From inception through December 31, 2024, Functional Brands raised approximately $3,237,683 in gross proceeds from stock sales at an average price of $1.28 per share. The company operates in the nutraceutical supplement industry through its Kirkman brand, which manufactures over 150 products in an FDA-registered facility, and in the hemp industry with various derived products. A 1-for-18.338622 reverse stock split was effected on January 22, 2025. The listing is contingent on Nasdaq approval, and failure to secure it will terminate the direct listing and the preferred stock private placement.

Why It Matters

This S-1/A filing signals Functional Brands' intent to go public via a direct listing, a less common route than an IPO, which means no new capital will be raised by the company from the initial public sales. The success of their $8,000,000 private placement is directly tied to this listing, impacting their future liquidity and growth. Investors face significant volatility risks due to the novel direct listing mechanism and the absence of an underwritten offering. The company's dual focus on the nutraceutical and hemp industries places it in competitive, yet growing, markets, with the Kirkman brand having a loyal customer base and over 2,000 doctors in 40+ countries.

Risk Assessment

Risk Level: high — The filing explicitly states, "Investing in our common stock involves a high degree of risk." The direct listing method is novel and may lead to more volatile trading than an underwritten IPO. Furthermore, the $8,000,000 private placement funding is "conditioned upon, among other things, completion of the Direct Listing," meaning a failure to list on Nasdaq would jeopardize this crucial capital infusion.

Analyst Insight

Investors should exercise extreme caution and thoroughly review the 'Risk Factors' section. Given the high volatility potential and the contingent nature of the private placement, a 'wait and see' approach until the Nasdaq listing is confirmed and initial trading patterns emerge is advisable.

Key Numbers

• 17,883,693 — Shares of Common Stock (Number of shares registered for resale in the direct listing)
• $8,000,000 — Private Placement Funding (Funding amount for Series A and Series B Convertible Preferred Stock, conditioned on direct listing)
• $10,000,000 — Stated Value of Preferred Stock (Stated value of Series A Convertible Preferred Stock)
• $80.00 — Aggregate Price Per Share (Price per share attributable to Series A and Series B Convertible Preferred Stock in private placement)
• $3,237,683 — Gross Proceeds from Stock Sales (Total gross proceeds from stock sales from inception through December 31, 2024)
• $1.28 — Average Price Per Share (Average price per share for stock sales from inception through December 31, 2024)
• 1-for-18.338622 — Reverse Stock Split Ratio (Ratio of reverse stock split effected on January 22, 2025)
• 1,240,665 — Shares Distributed by HOC (Shares of Functional Brands common stock distributed by HOC on August 5, 2025)
• 3,576,033 — Shares Exchanged by HOC (Shares of Functional Brands common stock exchanged by HOC on July 11, 2025)
• 1949 — Kirkman Brand Establishment Year (Year Kirkman brand was established)

Key Players & Entities

• Functional Brands Inc. (company) — Registrant, formerly HT Naturals Inc.
• MEHA (company) — Ticker symbol for Functional Brands Inc.
• Nasdaq Capital Market (regulator) — Intended listing exchange for MEHA
• Joseph Gunnar & Co., LLC (company) — Financial advisor for the Direct Listing and placement agent for private placement
• Eric Gripentrog (person) — Chief Executive Officer of Functional Brands Inc.
• Sichenzia Ross Ference Carmel LLP (company) — Legal counsel for Functional Brands Inc.
• Hemptown Organics Corp. (company) — Former majority owner of Functional Brands Inc.
• Kirkman (company) — Brand name for nutraceutical products under HTO Nevada Inc.
• SEC (regulator) — Securities and Exchange Commission
• Delaware (regulator) — State of incorporation for Functional Brands Inc.

FAQ

Risk Factors

• Reliance on Private Placement Funding [high — financial]: The company's direct listing is conditioned on the successful completion of a private placement of Series A and Series B Convertible Preferred Stock, raising $8,000,000. Failure to secure Nasdaq approval will terminate this private placement, potentially jeopardizing the company's funding strategy.
• Nasdaq Listing Approval Contingency [high — regulatory]: The direct listing of 17,883,693 shares is contingent upon Nasdaq approval. If Nasdaq does not approve the listing, the direct listing will be terminated, and the associated private placement will also be terminated.
• Dependence on Kirkman Brand [medium — operational]: The company operates primarily through its Kirkman brand, which manufactures over 150 nutraceutical supplement products. A significant disruption to this brand's operations or market demand could materially impact the company's financial performance.
• Competition in Nutraceutical and Hemp Industries [medium — market]: Functional Brands operates in the competitive nutraceutical supplement and hemp industries. The success of its Kirkman brand and hemp-derived products depends on its ability to differentiate and compete effectively against established and emerging players.
• Limited Historical Funding [low — financial]: From inception through December 31, 2024, the company raised only approximately $3,237,683 in gross proceeds from stock sales at an average price of $1.28 per share. This indicates a limited history of capital generation prior to the planned private placement.
• Reverse Stock Split Impact [low — legal]: A 1-for-18.338622 reverse stock split was effected on January 22, 2025. While intended to meet listing requirements, such splits can sometimes be perceived negatively by investors and may not guarantee future market performance.

Industry Context

Functional Brands operates in the nutraceutical supplement and hemp industries. The nutraceutical market, driven by increasing consumer focus on health and wellness, offers growth potential but is also highly competitive. The hemp industry is subject to evolving regulations and market acceptance, presenting both opportunities and risks.

Regulatory Implications

The company's direct listing is subject to Nasdaq approval, a critical regulatory hurdle. Failure to meet Nasdaq's listing standards would terminate the listing and the associated private placement. The company also operates in industries with specific regulatory oversight, particularly concerning supplement manufacturing and hemp-derived products.

What Investors Should Do

1. Monitor Nasdaq Listing Approval
2. Assess Post-Listing Shareholder Dilution
3. Evaluate Competitive Positioning of Kirkman Brand
4. Understand the Role of HOC

Key Dates

• 2025-01-22: Reverse Stock Split — A 1-for-18.338622 reverse stock split was effected, likely to meet minimum share price requirements for listing.
• 2025-07-22: Series A and B Convertible Preferred Stock Private Placement — The company completed a private placement raising $8,000,000, conditioned on the direct listing's success, providing crucial funding.
• 2025-08-05: HOC Distributed Shares — HOC distributed 1,240,665 shares of Functional Brands common stock, impacting the shareholder base.
• 2025-07-11: HOC Exchanged Shares — HOC exchanged 3,576,033 shares of Functional Brands common stock, indicating a change in share ownership.

Glossary

Direct Listing

A method for a private company to become publicly traded by listing its shares on an exchange without raising new capital through an underwritten offering. (Functional Brands is pursuing this method to list its shares, with no proceeds going to the company from the initial sales.)

S-1/A

An amendment to a registration statement filed with the SEC, typically used when a company is preparing to go public. (This document is the primary source of information for investors regarding Functional Brands' proposed direct listing.)

Convertible Preferred Stock

A class of preferred stock that can be converted into a specified number of common stock shares. (The company recently issued Series A and Series B Convertible Preferred Stock as part of a private placement, which is contingent on the direct listing.)

Reverse Stock Split

A corporate action in which a company reduces the total number of its outstanding shares by consolidating them. (Functional Brands effected a 1-for-18.338622 reverse stock split on January 22, 2025, likely to meet exchange listing requirements.)

Registered Stockholders

Existing shareholders who are registering their shares for sale in a public offering or direct listing. (The 17,883,693 shares being offered in the direct listing are by Registered Stockholders, not the company itself.)

Year-Over-Year Comparison

This S-1/A filing represents a significant step towards public listing, detailing a proposed direct listing of 17,883,693 shares by existing stockholders. It also highlights a recent $8,000,000 private placement of convertible preferred stock, conditioned on the listing's success. No direct comparison to a prior filing's financial metrics is possible as this is an initial registration statement for a direct listing, and historical financial data is not provided in a comparative format within this section.

Key Financial Figures

• $10,000,000 — Preferred Stock with a stated value of $10,000,000 for a funding amount of $8,000,000, tog
• $8,000,000 — of $10,000,000 for a funding amount of $8,000,000, together with a bonus Series B Convert
• $80.00 — Series B Convertible Preferred Stock is $80.00. The private placement documents were e
• $3,237,683 — we raised an aggregate of approximately $3,237,683 in gross proceeds from the sales of our
• $1.28 — les of our stock at an average price of $1.28 per share. Recent purchase prices of o

Filing Documents

• ea0258014-s1a11_functional.htm (S-1/A) — 3966KB
• ea025801401ex3-8_function.htm (EX-3.8) — 125KB
• ea025801401ex3-9_function.htm (EX-3.9) — 117KB
• ea025801401ex10-29_function.htm (EX-10.29) — 37KB
• ea025801401ex23-1_function.htm (EX-23.1) — 2KB
• ea025801401ex99-5_function.htm (EX-99.5) — 3KB
• image_001.jpg (GRAPHIC) — 24KB
• image_002.jpg (GRAPHIC) — 27KB
• image_003.jpg (GRAPHIC) — 31KB
• image_004.jpg (GRAPHIC) — 17KB
• image_005.jpg (GRAPHIC) — 30KB
• image_006.jpg (GRAPHIC) — 32KB
• image_007.jpg (GRAPHIC) — 33KB
• image_008.jpg (GRAPHIC) — 30KB
• image_009.jpg (GRAPHIC) — 37KB
• image_010.jpg (GRAPHIC) — 50KB
• image_011.jpg (GRAPHIC) — 36KB
• fin_001.jpg (GRAPHIC) — 2KB
• fin_002.jpg (GRAPHIC) — 15KB
• ex23-1_001.jpg (GRAPHIC) — 4KB
• ex23-1_002.jpg (GRAPHIC) — 5KB
• 0001213900-25-089355.txt ( ) — 4767KB

Business

Business 54 Management 84 Executive and Director Compensation 89 Certain Relationships and Related Party Transactions 91 Principal and Registered Stockholders 92 Description of Securities 120 Shares Eligible for Future Sale 123 Material U.S. Federal Tax Considerations for Non-U.S. Holders of Our Common Stock 124 Plan of Distribution 127 Legal Matters 130 Interests of Named Experts and Counsel 130 Experts 130 Where You Can Find More Information 130 You should rely only on the information contained in this prospectus or contained in any free writing prospectus filed with the Securities and Exchange Commission. Neither we nor any of the Registered Stockholders have authorized anyone to provide any information different from, or in addition to, the information contained in this prospectus and in any free writing prospectuses we have prepared or that have been prepared on our behalf or to which we have referred you. Neither we nor any of the Registered Stockholders take responsibility for, and can provide no assurance as to, the reliability of any other information that others may give you. The Registered Stockholders are offering to sell, and seeking offers to buy, shares of their common stock only under the circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since such date. For investors outside the United States: Neither we nor any of the Registered Stockholders have done anything that would permit the use of or possession or distribution of this prospectus or any related free writing prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of t

View Full Filing

View this S-1/A filing on SEC EDGAR